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Although pericardial diseases are common in the daily clinical practice and can result in a significant morbidity and mortality, imaging of patients
with suspected or knownpericardial disorders remain challenging.Multimodality imaging is part of themanagement of pericardial diseases. Echo-
cardiography, cardiac computed tomography, and cardiovascular magnetic resonance are often used as complementary imaging modalities. The
choice of one ormultiple imagingmodalities is driven by the clinical context or conditions of the patient. The scope of the present document is to
highlight the respective role of each technique according to the clinical context in the diagnosis and management of pericardial diseases.
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Introduction
Pericardial disease represents awide spectrumofprocesses involving
or damaging the pericardium. Imaging is essential for an appropriate
diagnosis of pericardial disease and its complications and plays an im-
portant role in its management. In addition to chest radiography,
threemainnon-invasive imaging techniques are available for assessing
the pericardium in clinical practice: echocardiography, cardiac com-
puted tomography (CT) and cardiovascular magnetic resonance
(CMR). All these imaging modalities have evolved over time and a
critical appraisal of their strengths and limitations is required for an
integrated use in order to address to specific clinical needs. The dif-
ferent imagingmodalities are often complementary and the choice of
one ormultiple imagingmodalities is driven by the clinical context or
conditions of the patient. The scope of the present document is to
highlight the respective role of each technique according to the clin-
ical context in the diagnosis of pericardial disease.
Imaging modalities in pericardial
disease
Among all imaging modalities that can be used for the evaluation of
pericardial disease, chest X-ray, echocardiography, cardiac CT, and
CMR are the most common. Chest X-ray is, however, of limited
value, unless the pericardial effusion is massive (typical bottle-like
shape cardiomegaly with large pericardial effusions) or pericardial
calcifications arepresent (,25%of casesof constrictivepericarditis).
An additional roleof chestX-ray is thedetectionof concomitant lung,
mediastinal, and pleural diseases that may be responsible of pericar-
dial manifestations (i.e. pulmonary tuberculosis, lung cancer).1
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Echocardiography
Transthoracic Doppler echocardiography is considered as the first-
line imaging modality in almost all types of pericardial diseases
because it is simple and quick to perform, widely available and
safe.2 However, two-dimensional (2D) echocardiography has
several weaknesses, mainly related to its dependence on a good
acoustic window, and to the inability to image the entire pericar-
dium.3 New developments may be helpful to reduce or to avoid
some of these limitations. Image quality has improved dramatically
with new probes with better crystals, better spatial resolution and
signal-noise ratio. The use of tissue harmonic imaging has also
improved the field of view reducing the inadequate examinations
to 5–10%. In contrast echocardiography, micro-bubbles small
enough to cross the pulmonary capillaries are injected intravenously
and opacify the left ventricular (LV) cavity and the myocardium. The
main application of contrast echocardiography is improved delinea-
tion of the endocardial border (better LV function and volumes as-
sessment), improved tissue characterization, and myocardial
perfusion. In pericardial disease, the use of contrast agents may
improve the detection of pericardial effusion especially in the acute
setting ofmyocardial infarction (MI)with pseudo-aneurysm and free-
wall rupture.4 TissueDoppler imaging velocity analysis is now part of
all echocardiographic examinations in patients with pericardial
disease for making the difference between constrictive pericarditis
and restrictive cardiomyopathy. A proposed e′ cut-off value
,7 cm/s supports the diagnosis of restrictive cardiomyopathy. De-
formation imaging has entered the clinical arena mainly to assess
the impact of various pathological conditions on ventricular function.
Strain is a measure of how much an object has been deformed, and
several formulas can be used to calculate different types of strain.
In cardiac imaging, strain is most often calculated as per cent or
fractional change in myocardial dimension, during each cardiac
cycle. Strain can be measured by echocardiography using tissue
Doppler,5 but the preferred modality is speckle-tracking echocardi-
ography (STE).6,7
In addition, echocardiography allows the assessment of the twist-
ing motion of the LV about its long axis.
LV rotation can bemeasured clinically by STE and twist and torsion
can be calculated.8,9 Twist refers to the absolute apex-to-base differ-
ence in LV rotation and is measured as twist angle and is expressed in
degrees. The term torsion refers to the base-to-apex gradient in ro-
tation angle along the LV long axis and is expressed in degrees per
centimetre.
In a normal individual, the heart slides and twists easily within the
parietal pericardium, which is lubricated by a small amount of fluid.
The importance of this motion has been illustrated in experiments
in which the epicardium was fixed to the pericardium.10 In this
study, pericardial adhesions reduced LV twist by limiting the free
motion of the heart inside the pericardium. Pericardial diseases
cause subepicardial tethering and predominant loss of circumferen-
tial strain andLV twistmechanicswhile relatively sparing subendocar-
dial function.11
Inpatientswith the congenital absenceof thepericardium, a reduc-
tion in LV twist has been reported.12 Consistent with this clinical ob-
servation from a small number of patients, it was observed in a dog
model that opening the pericardiumwas associated with a reduction
in LV twist.13 The authors speculated that the reduction in LV twist is
related to a change from elliptical to a more global shape of the LV
after pericardial opening.
Finally, three-dimensional echocardiography has the potential to
provide a complete evaluation of the entire pericardium in any ana-
tomical plane, and, therefore, todetect loculatedeffusions.Newsoft-
wares for an accurate quantification of the volume of liquid in the
pericardium are under evaluation.
Cardiac CT
CT is a widely available technique with a short acquisition time of a
few seconds. Modern computed CT scanners have a spatial reso-
lution well ,1.0 mm. High temporal resolution and dedicated
image acquisition techniques, which either trigger image acquisition
to the patient’s electrocardiogram or retrospectively select X-ray
data acquired during suitable segments of the cardiac cycle for
image reconstruction, provide for the ability to obtain data sets
largely free of motion artefact.14 While cardiac CT is in most cases
performed to visualize the coronary arteries, it does provide high-
resolution imagingof all cardiac structures, including thepericardium.
The pericardium can be visualized both in non-contrast and
contrast-enhanced CT data sets. Following the administration of i.v.
contrast, enhancement of thickened pericardium can be observed
in case of suspected pericarditis or tumour infiltration.3,15–17
However, the CT attenuation of pericardium is similar to that of
the myocardium. Hence, the pericardium can only be clearly visua-
lized, where it is surrounded by fat and not immediately adjacent to
the myocardium (Figure 1). It usually appears as a thin line and is
best delineated on the anterior face of the heart. Lack of visualization
by CT, especially on the posterior surface of the heart, is not a suffi-
cient criterion tomake the diagnosis of absent pericardium. Further-
more, CT is particularly sensitive for identifying pericardial
calcification. CT can obtain secondary functional information, such
as enlargement of the atria and venae cavae in cases of pericardial
constriction, but ventricular functional parameters can be acquired
onlywith retrospectiveECG-gated acquisitions,which are associated
with an increased radiation dose. Moreover, CT density measure-
ments may enable the initial characterization of pericardial fluid
better thanechocardiography.OnCT, generally, pericardial effusions
areof lowdensity in the rangeof0 to20Hounsfieldunits (HU).When
the effusion contains higher amounts of protein, such as in bacterial
infections, or when it is haemorrhagic, its density may raise to
50 HU and more. Inflamed pericardium may also show contrast
enhancement.18
CMR
CMRisauseful additional test for thediagnosisofmanypericardialdis-
eases, especially if echocardiography is equivocal, localized disease is
suspected, echocardiographic image quality is suboptimal or if add-
itional pathology is suspected. CMR can provide information on the
extent of pericardial disease, abnormalities in surrounding structures
and allows an accurate measurement of pericardial and related
structures. It provides superior tissue characterization including an
estimate of inflammation. Investigating pericardial disease with CMR
includes morphological imaging to assess pericardial structure
and to perform tissue characterization and functional imaging to
measure ventricular function and intracardiac flows.
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Black blood T1-weighted spin-echo CMR is used formorphological as-
sessment of the pericardium, the intrathoracic andmediastinal struc-
tures. Typically, a stack of axially oriented images covering the thorax
and further images in standardized cardiac planes, such as the LV
short axis, are acquired. From black blood images, the pericardial
thickness can be measured and any thoracic abnormalities, such as
lymphnodes, pleural effusions, or masses, can be identified.
Black blood T2-weighted spin-echo CMR images highlight fluid-rich
structures, such as pericardial effusion or myocardial oedema,
whichmay occur in concomitantmyocardial disease such asmyocar-
ditis. T2-weighted images are typically acquired in identical scan
planes as T1-weighted images and contribute to tissue characteriza-
tion of pericardial and other mass lesions.
High-resolution gradient-echo cine-images with steady-state-free-
precession pulse sequences are typically acquired in a stack covering
the heart in the LV short-axis planes and in orthogonal long-axis
planes. These images allow accurate quantitation of cardiac
chamber size and function, including pathological effects such as
RV/RA collapse. In pericardial disease, cine-images also contribute
to themeasurement of pericardial thickness and pericardial effusion.
Real-time cine imaging with fast but lower-resolution cine CMR
techniques is used to assess dynamic physiological effects of pericar-
dial disease such as ventricular interdependence. For this purpose,
real-time cine-images are typically acquired in the several LV short-
axis views and the horizontal long-axis views during respiration.
CMR tagging techniques can be added to the imaging protocol to
delineate adhesion of the pericardial layers in constrictive pericardi-
tis. These are best acquired in targeted planes depending on the
observed pathology.
Dynamic contrast-enhanced CMR imaging is recommended to assess
the blood supply of pericardial or cardiac mass lesions.
Late gadolinium enhancement (LGE) can be useful to assess inflam-
matory pericarditis, where the pericardium can show strong signal
enhancement, and concomitant myocardial pathology (e.g. myocar-
ditis). In addition, the method contributes to the tissue characteriza-
tion of masses.
Velocity-encoded CMR can be performed to delineate flow patterns
in suspected restrictive cardiac filling.
Advantages and limitationsof each imagingmodalities are summar-
ized in Table 1.
Normal findings
Normal anatomy and physiology
Understanding the anatomy of the pericardium as well as the inter-
action between pericardial pathology and cardiovascular function is
key to detecting and assessing pericardial disease. The pericardium
is a double-layered membrane, which forms a sac surrounding the
heart and the origin of the great vessels. The outer fibrous layer
has attachments to the surrounding structures, while the inner
serous layer lies adjacent to the surface of the heart. The external
surface of the heart is also covered with a simple serous membrane,
the epicardium, beneath which is a thin layer of dense fibrous con-
nective tissue and variable amounts of adipose tissue. The pericardial
lining secretes pericardial fluid (pericardial fluid volume normally
,35 mL of serous fluid), which lubricates the surfaces of the heart
and provides aminimal friction environment duringmechanical func-
tion. At the base of the heart, the reflections of the pericardial sac
between the great vessels form several extensions of the pericardial
cavity called pericardial sinuses: the transverse sinus, dorsal to the
ascending aorta, and the oblique sinus located behind the left
atrium (LA), so that the posterior wall of the LA is actually separated
from the pericardial space.
In normal conditions, in the absence of pericardial disease, the dis-
crimination of the pericardium from the myocardium, using imaging
Figure 1: Visualization of the pericardium in computed tomography. Both in non-contrast acquisitions (A) as well as in contrast-enhanced
acquisitions (B), the pericardium can be visualized as a thin line embedded in the epicardiac and paracardiac fat (arrows) Where the pericardium
is immediately adjacent to the myocardium, it can often not be visualized. Frequently, this is the case along the posterior margin of the heart.
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Echocardiographically, the pericardium is visualized as a thin, hyper-
echogenic linear echo-dense structure surrounding the heart, most
evident at the posterior cardiac interface. The pericardium can
usually be visualized in all standard echocardiographic windows
such that diffuse pericardial pathology can be observed in most
views. Localized pericardial disease, such as loculated fluid collec-
tions or haematomas, may require more focused examinations. In
patients with pericardial fluid or infiltration, the pericardium
appears more prominent and distinction between the parietal and
visceral layers is often more evident. Normal pericardial thickness
is ,3 mm, but its appearance on transthoracic echocardiography is
influenced by image quality and instrument settings. In general, for
the evaluation of pericardial thickness, sensitivity is greater with
transoesophageal than transthoracic echocardiography. However,
accuracy is higher with other imaging modalities, such as cardiac
CT or CMR.
Cardiac CT
Whenassessing the thicknessof thepericardium, carehas tobe taken
to assure that measurements are made in planes, which provide an
exactly orthogonal viewonto the pericardium. The normal thickness
of the pericardium on high-resolution CT scans was found to be
between 1 and 2 mm, the upper limit of normal of the thinnest
point of the pericardium was 0.7 mm in thin-slice CT and 1.2 mm
in thick-slice CT.19 The upper limit of normal of the thickest
section is 2 mm inhigh-resolutionCT.3,16However, even thicknesses
up to 4 mmhave been reported as normal.3,20 Themost problematic
issue regarding the assessment of pericardial thickening is the fact
that, again due to an overlap in CT attenuation values, it may be diffi-
cult to distinguish a slightly thickened pericardium from small collec-
tions of pericardial fluid (Figure 2).
CMR
The normal pericardium is best measured from black blood
spin-echo or cine gradient-echo CMR images, where it appears as a
thin low-intensity layer surrounded in most regions by high-signal
fatty tissue.21,22 Normal pericardium on CMR is usually considered
to be ,2 mm thick, but analogous to CT, an upper limit for normal
pericardial thickness has not been conclusively defined. CMR also
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Table 1 Advantages and limitations of imaging modalities in pericardial disease
Echocardiography Cardiac CT CMR
Advantages
First line for diagnosis and
follow-up
Better anatomic description Better anatomic description
Widely available Evaluation of associated/extracardiac disease Evaluation of associated/extracardiac disease
Low cost Pre-operative planning Pre-operative planning
Safe and repeatable Detection of pericardial calcification Repeatable
Bedside (critically ill and pericardiocentesis)
Modalities
M-mode Axial imaging Bright blood-single-shot SSFP
Two-dimensional
echocardiography
Multiplanar reconstruction Black blood images (+STIR)
Doppler Volume rendered imaging Tagged cine-images
Tissue Doppler velocities Cine-imaging Bright blood cine-images
Deformation Imaging Late gadolinium enhancement images




Limited windows Ionizing radiation Time-consuming, high cost
Poor quality imaging Iodinated contrast Difficult in case of arrhythmias
Operator dependent Functional evaluation only possible with
retrospective-gated studies
Contraindicated with some devices (pacemakers, AICD. . .)
Limited tissue characterization Difficult in case of arrhythmias Calcifications not well visualized
Need for breath-hold Gadolinium not recommended if glomerular filtration rate
,30 mL/min)
Haemodynamically stable patients only Need for breath-hold
Haemodynamically stable patients only
SSFP, steady-state-free precession; STIR, short inversion time inversion-recovery.
Adapted from Verhaert et al.15
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allows the assessment of the transverse pericardial sinus and the pre-
aortic and retro-aortic pericardial recesses. The pericardial space
normally contains a small amount of pericardial fluid that can be
demonstrated on black blood and cine-images. On cine-images, un-
restricted movement of the myocardium against the pericardium is
observed in normal cases.
Use of non-invasive imaging
in various clinical scenarios
Acute pericardial disease
The clinical syndromeof acutepericarditis is commonly encountered
in clinical practice (Figure 3). According to the 2004 ESC recommen-
dations,23 acutepericarditismaypresentwithorwithout clinical signs
of cardiac tamponade. Cardiac tamponade requires a specific man-
agement as set out below. The use of the available non-invasive
imaging modalities for the management of each individual patient is
guided by the initial findings and clinical course.24 A distinction
between patients with a non-complicated course and/or small
amount of effusion and patients with a complicated course (recur-
rence, refractory to medical treatment) and/or moderate or large
amount of effusion has to be made.
In most patients, the cause of acute pericarditis is thought to be
idiopathic because the yield of diagnostic tests to confirm aetiology
has been relatively low. Known causes include viral and bacterial
micro-organisms (especially tuberculosis which nowadays repre-
sents the most important cause of pericardial diseases all over the
world), systemic diseases, neoplastic invasion of the pericardium,
uraemia, invasive cardiothoracic procedures, and chest trauma.25
Tuberculous pericarditis is still a major cause of the disease in devel-
oping countries and also in immunocompromised patients, like
patients with AIDS. Acute pericarditis has been reported in as
many as 25% of post-MI patients, and may also occur in association
with acute aortic dissection.26
In the vastmajority of patients, the diagnosis of acute pericarditis is
easilymade, basedon the historyof chest pain, the presenceof a peri-
cardial friction rub, and the typical changes on electrocardiogram.
Elevated markers of acute inflammation are often present.27
Echocardiography remains the initial imagingmethod of choice for
the majority of patients in whom acute pericarditis is suspected and,
mostof the times, it is theonly imagingmodality needed.Detectionof
pericardial effusion is considered diagnostic criteria for pericarditis.28
Uncomplicated acute pericarditis/small amount
of or no effusion
Although inpatientswith a clear diagnosisof uncomplicated idiopath-
ic acute pericarditis imaging may not be required, the threshold
for ordering a transthoracic ehocardiogram (TTE) is usually low.
Although a pericardial effusionmay be absent in amajority of patients
with acutepericarditis (up to60%), it is useful to confirmthediagnosis
when a pericardial effusion is found. In most cases, pericardial effu-
sions are small and not a cause for concern.
Echocardiography can also be useful when the diagnosis is uncer-
tain to assist in the differential diagnosis with acute coronary syn-
drome, aortic dissection, and pulmonary embolism. It may also be
valuable to unmask the underlying cause of pericarditis or, in patients
who have concomitant myocarditis and elevated troponin values, to
delineate if associatedmyocarditis is severe enough to alter ventricu-
lar function. No other imaging modalities are usually required in this
setting. CMR may be of added value in the clinical context of asso-
ciated myocarditis even in the absence of wall motion abnormalities
on echocardiography.
Recommendations
Acute pericarditis with small or no effusion
(non-complicated course)
Class
TTE to confirm clinical diagnosis Recommended
CMR to confirm clinical diagnosis if clinical context
of myocarditis
Recommended
CT/CMR to confirm clinical diagnosis if
echocardiography inconclusive
Not recommended
TOE if poor TTE quality of imaging Not recommended
TTE for follow-up Not recommended
Complicated acute pericarditis/moderate-to-large effusion
without tamponade
TTE is advised when pericarditis is associated with indicators of
worse outcome (fever >388, subacute course, or failure of initial re-
sponse to standard therapy), andmandatorywhen there is suspected
or knownprevious heart disease, concern for features of constrictive
physiology (in cases of prolonged or recurrent pericarditis). More-
over, by exclusion of a large pericardial effusion, 2D echocardiog-
raphy is particularly helpful to assist in the decision to treat patients
Figure 2: Small accumulations of fluid can mimic pericardial
thickening in CT, since the CT attenuation of fluid and pericardial
tissue can overlap. Here, some pericardial fluid creates the impres-
sion of thickened pericardium anterior to the right ventricle
(arrows).
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in an outpatient setting, whenever other poor prognostic indicators
are absent. According to the aetiology of pericarditis, the acute in-
flammatory response can produce either serous (more common in
viral pericarditis) or haemorrhagic and exudative fluid (the case of tu-
berculous, neoplastic, and purulent pericarditis). Depending on the
velocity of the fluid accumulation and on the total volume reached,
diastolic filling of the right heart may be impaired, even in the
absence of clinical cardiac tamponade. This situation may require
drainage and aetiology search, because large pericardial effusions
are more frequent in pericarditis of non-idiopathic origins. Peri-
cardiocentesis is also indicated whenever tuberculous or purulent
aetiology is suspected, or for large or symptomatic effusions refrac-
tory to medical treatment.29,30
Additional examinations (TOE, CT, and CMR) can be proposed
when TTE is non-diagnostic (obstructive lung disease, obesity, early
after cardiac surgery). It is also reasonable to move to CT or, in
stable patients, CMRwhen there is a traumatic aetiology, particularly
when associated lesions in adjacent structures are suspected (pene-
trating injury, gastric, or oesophageal perforation). Both CT or CMR
are indicated when pericarditis is associated with neoplastic diseases
(lung or breast tumours), for the evaluation of the extension and
staging of the disease and also post-MIwhen doubts persist regarding
thepossibilityof haemopericardiumsecondary tocontainedmyocar-
dial free-wall rupture. In patients with recurrent pericarditis, CMR
may help monitoring the presence and severity of active inflamma-
tory changes, guiding the clinician in respect to the continuance of
anti-inflammatory therapy.31
Pericardial fluid can reliably be detected by CT and is often an in-
cidental finding.32 Small amounts of fluid in the pericardial space and
pericardial recesses, especially in the posterior and inferiormargin of
theheart, aswell as aroundthe left atrial appendage, can frequently be
observed in healthy individuals.16 In cases of pericardial effusion, CT
can clearly delineate the anatomic distribution of pericardial fluid
(Figures 4 and5).CTattenuationnumbersmeasured in thepericardial
Figure 3: Proposed algorithm for imaging acute pericardial disease. CMR, cardiac magnetic resonance imaging; CT, computed tomography;
FUP, follow-up.
Figure 4: Normal accumulation of pericardial fluid around the
inferior margin of the heart (arrows).
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fluid may give some hints regarding the type and genesis of the effu-
sion. Densities higher than water (above 10 HU) suggest a high
protein content. The density of haemorrhagic effusions is typically
.30 HU. However, in cases of older haemorrhagic effusions, the
density decreases over time.16 For the identification of acute haem-
orrhagic when compared with non-haemorrhagic effusions, a CT at-
tenuation value .30 HU provided a sensitivity of 100% and
specificity of 70%.33
By CMR, pericardial effusions are clearly demonstrated with cine
and black blood images. CMR provides more detailed visualization
of pericardial effusion than transthoracic echocardiography,
especially of loculated or regional effusions and can guide pericardio-
centesis (Figure 6). Through wider coverage of the thorax, CMRmay
identify the cause of a pericardial effusion and related pathology such
as tumouror aortic disease. Signal characteristicswith different CMR
techniquesmayhelpdifferentiatebetween transudates andexudates:
transudates typically have low signal on T1-weighted CMR images
and high signal on gradient-echo cine-images, while protein-rich exu-
dates showhigh signal on T1-weightedCMR. Signal characteristics of
haemorrhagic effusions depend on the duration of the pathology. In
acute pericarditis and myo-pericarditis, high signal in the pericardial
layers on late gadolinium enhanced CMR images suggest acute
Figure 5: Circular pericardial effusion in transaxial orientation (A) and a ‘short-axis’ multiplanar reformatted image (B).
Figure 6: Loculated pericardial effusion (arrows) demonstrated with cine CMR images in orthogonal planes.
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inflammation (Figure 7).34 Features of associated myocarditis are mid
or epicardial areas of high signal on T2-weighted images (myocardial
oedema), T1-weighted early gadolinium enhancement images
(hyperaemia or capillary leak) and LGE images (oedema and/or fibro-
sis) together with regional wall motion abnormalities on cine




moderate-to-severe effusion and no tamponade
Class
TTE to confirm clinical diagnosis Recommended
TOE if poor TTE quality of imaging Recommended
TTE to indicate, contraindicate pericardiocentesis Recommended
TTE to guide and for follow-up of pericardiocentesis Recommended
CT/CMR to confirm clinical diagnosis in case of high
suspicion of aortic dissection
Reasonable
CT/CMRtoconfirmthe clinical diagnosis in caseof trauma
or associated disorders
Reasonable
CT/MRI to confirm clinical diagnosis if echocardiography
inconclusive
Reasonable
CMR to confirm clinical diagnosis in case of myocarditis Recommended
CMR for follow-up of pericardiocentesis Reasonable
TTE for follow-up Reasonable
Specific clinical conditions
In particular clinical conditions, the recommendations have to be
adapted. Pericarditis is not infrequent in patients with severe renal
failure and usually resolves with free-heparin daily haemodialysis. In
these patients, the use of CT with contrast is not recommended
due to nephrotoxicity of these products. Similarly, gadolinium-based
contrast agents in CMR should be used with caution or avoided in
patients with advanced renal failure (glomerular filtration rate
,30 mL/min/1.73 m2) because of the risk of nephrogenic systemic
fibrosis.37
Pericardial effusion is a common complication of MI and may be
attributed to epicardial irritation in transmural infarction, increased
in venous and capillary pressure in heart failure, or subacute LV
wall rupture. Pericardial effusion is generally small.
Cardiac tamponade occurs in 1% of patients with fibrinolytic-
treated acute MI and is associated with increased 30-day mortality.
Time from symptom onset to treatment strongly predicts the de-
velopment of tamponade, underscoring the need for continued
efforts to increase speed to revascularization in acute MI. Increasing
age, anterior MI location, female sex, and increased time from
symptom onset to treatment are significant independent predictors
of tamponade. In post-infarction patients, the use of contrast echo-
cardiography can help to diagnose pseudo-aneurysm or free wall
rupture. Meta-analysis has even shown a beneficial effect in terms
of prognosis in this setting.4 In this population, CMR allows the as-
sessment of the extent and staging of the disease. If doubts persist,
CMR’s ability to detect the presence of haemopericardium may
support indirectly the diagnosis of contained myocardial free-wall
rupture. Irradiation is of particular concern in pregnant women
presenting with pericardial disease, or in foetuses with pericardial
disease.38 For this reason, CT is contraindicated during pregnancy.
Although CMR can be used safely in this condition, it is not
routinely recommended, and echocardiography remains the exam-
ination recommended.
Figure7: Acutepericardial inflammationdemonstratedwith late
gadolinium enhanced CMR.
Figure 8: Mid-myocardial enhancement on late gadolinium
enhanced CMR (arrow) in acute myocarditis.
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Recommendations
Imaging pericardium in specific conditions
A. Renal failure Class
TTE to confirm clinical diagnosis Recommended
TOE if poor TT quality of imaging Recommended
TTE for diagnosis, guiding and follow-up of
pericardiocentesis
Recommended
CT/CMR to confirm clinical diagnosis if
echocardiography inconclusive (except
non-contrast CT or CMR)
Not recommended
B. Post-infarction
TTE to confirm clinical diagnosis Recommended
Contrast echocardiography (aneurysm, free wall
rupture)
Reasonable
TOE if poor TT quality of imaging Reasonable





TTE to confirm clinical diagnosis Recommended
CT/CMR to confirm clinical diagnosis if
echocardiography inconclusive
Not recommended
TTE for guiding and follow-upof pericardiocentesis Recommended
D. Foetal
TTE to confirm clinical diagnosis Recommended




Cardiac tamponade is a condition involving compression of the heart
caused by blood or fluid accumulation in the pericardial sac and
occurs when the pressure in the pericardial space exceeds the pres-
sure in one or more cardiac chambers causing decreased cardiac
output. Occurrence of tamponade can be acute, subacute, regional
(or characterized by low pressure). Blood or fluid collects within
the pericardium and this prevents the ventricles from expanding
fully in diastole so they cannot adequately fill, and thus, pump
enough blood to meet metabolic requirements. Acute tamponade
is sudden and life threatening if not treated promptly. It is an emer-
gency clinical condition often associated with hypotension, as well
as chest pain and dyspnoea, and should be suspected in patients in
cardiogenic shock, especially if they have increased jugular venous
pressure or pulseless electrical activity. Cardiac tamponade always
requires hospitalization. It occurs when the pericardial space fills
up with fluid faster than the pericardial sac can stretch. If the
amount of fluid increases slowly (such as in hypothyroidism) the peri-
cardial sac can expand to contain up to 1–2 L before the occurrence
of cardiac tamponade. If the fluid occurs rapidly as it may occur after
trauma, cardiac surgery or myocardial rupture, as little as 200–
300 mL can cause cardiac tamponade.
The presence of pericardial effusion in tamponade can readily
be identified with echocardiography.39 Typically, the heart is of
normal size. Both the atria and the ventricles are small (underfilled)
with good systolic function (compensatory hyperkinesis). Pericardial
effusion is often symmetrical, both anteriorly and posteriorly from
parasternal long- or short-axis projections, but also posteriorly,
behind the posterior wall (Figure 9). In ambulatory patients, the peri-
cardial effusion will be more important near the LV posterior wall,
due to the effects of gravity. In bed-bound patients, either following
surgery or any cardiac interventions, the effusion may be predomin-
antly anterior. Unless the effusion is very large, the rate of fluid accu-
mulation determines the development of tamponade, rather than its
size. It is possible to have tamponade with only a small pericardial ef-
fusionof 10 mm, if the fluid is rapidly developing.Conversely, no tam-
ponade may be present even with a large pericardial effusion, if it has
accumulated slowly.
It is generally easy to estimate the amount of pericardial effusion by
measuring the sizeof effusion in centimetres, usually fromparasternal
projections, perpendicular to the ventricular walls in diastole
(1) Minimal pericardial effusion, usually of no haemodynamic conse-
quences, when seen only in systole;
(2) ,1 cm: will correspond to 300 mL;
(3) 1–2 cm: 500 mL;
(4) .2 cm: typically in excess of 700 mL.
(5) ‘Swinging heart’: this is a large pericardial effusionwheneffective-
ly the heart wobbles and is often associatedwith tamponade and
electrical alternance on the ECG.
Apical and subcostal projections arealso important inorder todeter-
mine the extent of effusion if there is clinical evidence of tamponade,
to identify the optimal location for pericardiocentesis.
In patients with tamponade, there may be a large respiratory vari-
ation in chamber dimensions. Figure 10 is an M-mode echocardio-
gram from a patient with cardiac tamponade. It shows an
inspiratory increase of RV size with concomitant decrease in LV
size. Conversely, during expiration theRV is reduced in sizewith con-
comitant increase in LVsize.Note that there isonly a small concentric
pericardial effusion at 1 cm. While normally the atria are con-
strained within the pericardium, in tamponade, there is typically an
early diastolic collapse of the RA free wall better seen from apical
four-chamber projections (Figure 11).
Figure9: Parasternal short-axis view fromapatientwithmoder-
ate concentric pericardial effusion (arrows). LV, left ventricle;
PE, pericardial effusion.
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Ventricular interdependence: normally, the pericardium
allows the normal left and right ventricular filling to occur
without restriction. When there is pericardial tamponade, the
right ventricle cannot expand in diastole when it fills, so the ven-
tricular septum shifts to the left, and the left ventricle then
becomes underfilled. This shifting of the ventricular septum can
be elicited by respiratory manoeuvres. It is a reflection of ven-
tricular interdependence and can be recognized in both pericar-
dial tamponade and pericardial constriction. Doppler assessment
provides unique information regarding the haemodynamics of
pericardial tamponade.39
In a normal individual, changes in intrathoracic (pleural) pressures
are faithfully transmitted almost equally to the cardiac chambers, and
pulmonary veins and capillaries. Thus, the effective filling gradient
(EFG) of the LV (pressure difference between pulmonary capillaries
and left ventricle) changes only slightly through the respiratory cycle.
In patients with tamponade; however, changes in intrathoracic pres-
sure are transmitted well to the pulmonary veins and capillaries but
arepoorly transmitted to the left ventricle due toadistendedpericar-
dial sac. Therefore, the EFG of the LV is markedly reduced during in-
spiration compared with expiration, resulting in reduced LV filling
and, therefore, reduced LV outflow and stroke volume.1
As a result, the followingDoppler features are observed during in-
spiration: in the left heart, there will be a reduction in EFG due to a
reduction in pulmonary capillary pressure while LA and LV diastolic
pressures are relatively maintained due to reduced transmission of
intrathoracic pressure into the heart. Therefore, LV filling will be
reduced. Consequently, the transmitral Doppler early diastolic
(E)-wave and in turn LV outflow will be reduced. In the right heart,
the opposite is observed; RV filling is increased with increased RV
volume as the septum moves to the left (ventricular interdepend-
ence), increased tricuspid E-wave and increased RV outflow velocity
(Figure 12).
In cases where haemodynamic assessment with echocardiog-
raphy is atypical and the presence of cardiac tamponade is still
uncertain, CMR provides a useful adjunct or confirmatory test
to exclude localized or loculated tamponade, but has limited indi-
cation in urgent cases. The CMR criteria for a functionally import-
ant effusion are similar to echocardiography, but may be more
readily identified if echocardiographic images are of substandard
quality; diastolic compression of the RV free wall, early systolic
collapse of the RA, distortion of the LV and RV morphology, and
potentially displacement of the interventricular septum to the
left side during early inspiration (ventricular interdependence,
Figure 13), although this is more commonly seen in constrictive
pericarditis.40,41
Although, CT and CMR have no role in acute life-threatening
cardiac tamponade, CT may help to determine the feasibility of per-
cutaneous pericardiocenthesis especially in loculated or complex
effusions.42
Figure 10: M-mode echocardiogram demonstrating a reduced
RV size during inspiration (I) with a concomitant increase in LV
size. During expiration (E), the RV expands while the LV size is
reduced. IVS, interventricular septum; LV, left ventricle; RV, right
ventricle. Note that the pericardial effusion (arrows) is only mild
(1 cm).
Figure 11: Apical projections from a patient with a moderate pericardial effusion (left) with diastolic RA collapse (right) suggestive of pericardial
tamponade (arrow). LV, left ventricle. RA, right atrium.
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Pericardiocentesis
Patients with tamponade
In patientswith tamponade, pericardiocentesismay be life-saving and
should be performed quickly when the diagnosis of tamponade has
been made. The biggest advantage of echocardiography is that it is
a non-invasive bedside investigation and therefore, uniquely placed
for both the diagnosis and guidance of drainage of the effusion.
Other imaging modalities such as CMRmay provide similar informa-
tion to echocardiography about the presence of effusion, but only
limited information about haemodynamics, which effectively consti-
tute the diagnosis of tamponade. In addition, theymay delay a poten-
tially life-saving pericardial drainage and therefore, are not
recommended as first-line imaging modality in this setting.
Drainage of an acute or chronic effusion producing cardiac tam-
ponade may be performed with percutaneous pericardiocentesis
or subxiphoid pericardiotomy. Percutaneous pericardiocentesis
has been described in detail by several authors43–47 who proposed
improvement of the technique from the blind procedure through
echo-guided and contrast echo-guided pericaridocentesis. The pre-
viously used subcostal blind puncture of the pericardium has been
abandoned because of the significant incidence of complications
andmortality.48 Numerous investigators have recognized the useful-
ness and safetyof 2Dechocardiography-guidedpericardiocentesis to
reduce the riskof cardiacpuncture.Theadditionof contrastechocar-
diography can further improve the safety of the procedure by redu-
cing the likelihood of heart puncture. During the procedure, the ideal
entry point (minimal distance from skin to pericardial fluid without
intervening structures) can be defined by echocardiography. The
subxiphoid approach has been used most commonly, with a long
needle with a mandrel (Tuohy or thin walled 18-gauged) directly to
the left shoulder at a 308 angle to the skin. This route is extrapleural
and avoids the coronary, pericardial, and internal mammary artery.
The operator, under echo assistance, attempts to aspirate fluid and
inject immediately after 6 mL of agitated saline thus confirming that
the needle is entered into the pericardial sac (microbubbles should
clearly create contrast into pericardial fluid) (Figure 14). After the
correct introduction of the needle, a guidewire and a catheter (gen-
erally multi-holed pig-tail) may be advanced into the pericardial sac
and drainage may be performed. The Tuohy needle from the subxi-
foid approach thanks to its curved tip greatly facilitates guidance of
the wire and catheter to the posterior pericardial space so that the
standard Seldinger technique may be successful not only in massive
and diffused effusions, but also in loculated posterior ones.47
Another alternative approach (vs. subxiphoid pericardiocentesis)
has been proposed either in acute medical or post-cardiac surgical
tamponade or for cardiac perforation complicating catheter-based
procedures.49 Two-dimensional echocardiography allows the exam-
iner to locate the largest collectionof pericardial fluid in closest prox-
imity to the transducer. Accordingly the apical or anterior route may
be decided. The role of echo and contrast saline is the same as in the
previous described subxiphoid procedure.
Both in subxiphoid and apical approaches, echo-guided peri-
cardiocentesis may be further improved in terms of safety and mon-
itoring by fluoroscopic guidance.
Using an intrapericardial catheter for extended drainage (vs. peri-
cardiocentesiswithout pericardial catheter) is safe andmaybeeffect-
ive in order to decrease recurrences; this has been demonstrated in
retrospective series (the majority with malignancies).50,51 Thus, a
complete and prolonged evacuation of the fluid may probably
enhance apposition of the visceral and parietal pericardium.
Surgical drainage of a pericardial effusion is usually performed
through a limited subxiphoid incision.52–55Generally, themore inva-
sive technique (subxiphoid surgical pericardiotomy)may be selected
in cases in which percutaneous pericardiocentesis is unsuccessful or
when echocardiographic examination discourages a percutaneous
approach.
Complications of pericardiocentesis are rare when echo and
fluoroscopic guidance are used correctly. Echocardiographic moni-
toring throughout the procedure is very useful. Immediately after
the drainage signs of clinical tamponade (heart rate, arterial pressure)
should be monitored, as well as echo findings such as, changes in
cardiac chamber compression and mitral and aortic flow. Generally,
Figure 13: Interventricular dependence in constrictive pericar-
ditis on real-time cine CMR. The interventricular septum bulges
towards the left ventricle on early inspiration (arrow).
Figure 12: (A) On the left side, during inspiration, the mitral
inflow is reduced almost immediately and increased during expir-
ation (arrowheads) (B) On the right side, there is an increase of tri-
cuspid E-wave and a reduction during expiration (arrowheads).
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signs of compression (both right atrial and ventricular collapse) and
inspiratory variation of left-side valve flow disappear immediately
after the initial drainage of the pericardial sac (even with a few milli-
litre of pericardial drainage). The complete or almost complete re-
duction of pericardial effusion may be continuously monitored by
echo using an ideal view (generally the four-chamber view during
the subxiphoid pericardiocentesis).
Depending on the clinical presentation and clinical findings, after
pericardial drainage, an individualized echo follow-up may be sched-
uled in each patient. Generally, inside the hospital, a daily check may
be performed to evaluate pericardial effusion recurrence. After
patient discharge, a weekly echocardiographic evaluation may be
useful to facilitate the clinician in choosing the correct medical strat-
egy. There are no rules to check changes in the quantity of pericardial
effusion (small, moderate, and severe), but digital storage of a
complete examination may certainly facilitate comparisons among
several echocardiograms.
Generally, echocardiography remains themethodof choice for the
follow-up of pericardial diseases in themajority of cases. However, in
many clinical scenarios, echocardiography alone may be insufficient.
This is certainly true in the diagnostic process, but may be also con-
sidered in the follow-up of complex cases even though these consid-
erations are largely based on individualized approaches. Given that it
does not expose patients to ionizing radiation and that it provides
freely definable imaging planes, CMR is an ideal test for the longi-
tudinal follow-up of patients with pericardial disease.
Patients without tamponade
Pericardial drainage in the absence of cardiac tamponade or signs of
haemodynamic impairment is still controversial. However, nearly
Figure 14: Echocardiography without andwith contrast injection before pericardiocentesis. RV, right ventricle; LV, left ventricle; LA, left atrium;
PE, pericardial effusion; Cath, drainage catheter; L, leaver.
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one-third of patients with large idiopathic pericardial effusions
develop cardiac tamponade unexpectedly.56 Routine pericardial
drainage procedures have a very low diagnostic yield in patients
with large pericardial effusion without tamponade or suspected
purulent pericarditis and no clear benefit is obtained with this ap-
proach.57 In general, outcomes depend on the underlying diseases
and are not influenced by drainage of pericardial fluid.58 However,
in many advanced malignancies, pericardial drainage may be asso-
ciated with instillation into the pericardial sac of different agents
with sclerosing or cytostatic activity, like tetracyclines, belomycin,
thiotepa, or radionuclides.59–61
Imaging in specific conditions potentially requiring pericardiocentesis
Pericardial effusion after invasive procedures. The incidence of cardiac
perforation and pericardial tamponade is increasing in the era of
new coronary interventional devices. Tamponade after percutan-
eous coronary intervention is not rare (overall incidence 0.2%); it
can have a delayed off-set and thus, occur outside the catheterization
suite.62 The same is true for electophysiological procedures. There-
fore, echocardiographically guided rescue pericardiocentesis for
cardiac tamponade after catheter-based procedures has been exten-
sively studied. This method appears safe and effective for reversing
haemodynamic instability.49 The importance of an immediate drain-
age in different cardiac catheter-based procedures is further under-
lined in recent years due to several new ‘complex’ procedures
including left atrial appendage closure, mitral clip, transfemoral
aortic valve implantation, and others.
Haemopericardium is not rare after cardiac catheter-based
procedures and echo-guided pericardiocentesis is much more
important in this situation since the operator may immediately
excludeheart puncture. In apatient population that is reasonably rep-
resentative of that in most community hospitals in the USA,63 the
most common cause of bloody pericardial effusion in patients with
signs or symptoms of cardiac tamponade is now iatrogenic disease.
Of the noniatrogenic causes, malignancy, complications of acute
MI, and idiopathic disease predominated. Fluoroscopy-guided
pericardiocentesis has also been demonstrated as a safe and effective
management strategy for cardiac tamponade developed in the cardiac
catheterization laboratory. A reduction in the excursion of cardiac
silhouette on fluoroscopy is an early diagnostic sign of cardiac
tamponade.64
Pericardial effusion and cardiac tamponade after cardiac surgery.
Pericardial effusion is not a rare complication of cardiac surgery.65,66
Haemodynamic instability due to pericardial effusion occurs in
1.5% of patients, and symptoms are frequently non-specific. Virtu-
ally, all pericardial effusions are generally found by the fifth post-
operative day; they peak on the 10th day and resolve within 1
month. However, late cardiac tamponade has also been described67
and haemodynamic impairment has several differences in compari-
son with ‘medical’ effusion. In fact loculated effusions are very fre-
quent (up to 58%) and 6% of cases may have isolated effusion
along the right atrial wall. Pericardial clots particularly at the level
of the right chambers may produce low-cardiac output soon after
open-heart surgery, with haemodynamic signs that are very similar
to constrictive pericarditis. Transoesophageal echocardiography
may be indicated in these cases to image adequately the right
atrium, the junction between the superior vena cava and the
atrium and the pericardial clot.68 Alternatively, CT or CMR may
be used. In all these cases echocardiography is very useful in
choosing the more correct approach to relieve cardiac tamponade
(percutaneous pericardiocentesis, subxiphoid surgical drainage, or
even pericardial inspection after sternotomy in cases in whom
bleeding is suspected). Figure 15 shows an example in which peri-
cardiocentesis was not appropriate (loculated haematoma com-
pressing the right atrium and LA), and urgent cardiac surgery was
performed to relieve cardiac compression.
Recommendations
Cardiac tamponnade and pericardiocentesis Class
TTE to confirm clinical diagnosis Recommended
TOE if poor TTE quality of imaging Recommended
TTE to indicate, contraindicate pericardiocentesis Recommended
TTE to guide and for follow-up of pericardiocentesis Recommended
CT/CMR to confirm clinical diagnosis in case of high
suspicion of aortic dissection
Reasonable
CT/CMR to confirm the clinical diagnosis in case of
trauma
Reasonable
CT/CMR to confirm clinical diagnosis if
echocardiography inconclusive
Not recommended
CMR for follow-up of pericardiocentesis Reasonable
Constriction
Chronic constriction
Constrictive pericarditis is a condition caused by a thick non-
compliant inflamed, fibrotic, and/or calcified pericardium, which
inhibits cardiac filling by preventing full transmission of respiratory
intrathoracic pressure changes to cardiac cavities. Constrictive
pericarditis is mainly related to cardiac surgery, pericarditis, and me-
diastinal radiation therapy in the developed countries.69,70 Immuno-
suppression and tuberculosis areothercausesof constriction, inboth
developed and underdeveloped countries.71 In chronic constriction,
there is no pericardial effusion. Perhaps the sign that is most obvious
and should alert the echocardiographer towards the diagnosis of
constriction is the abnormal ventricular septal motion to the left in
early diastole, in inspiration, as in pericardial tamponade due to the
ventricular interdependence (septal bounce). This is exaggerated
during inspiration where the RV fills ahead of the LV and pushes
the septum to the left. As in pericardial tamponade, the now thick-
ened pericardium prevents full transmission of respiratory changes
of intrapleural pressures to the intracardiac cavities, creating a
marked respiratory variation in the left-side pressure difference
between the pulmonary vein and the LA, which is reduced during in-
spiration (reduced EFG). Therefore, themitral inflow and pulmonary
venous diastolic flow velocities decrease immediately after the onset
of inspiration and increase with expiration (≥25% expiratory
increase in transmitral E-wave velocity). Changes in the right side
are the opposite and reciprocal with inspiratory increase of tricuspid
inflow (≥40% inspiratory increase in transtricuspid E-wave velocity)
and outflow.72
Otherechocardiographic findings includeanormal ventricular sys-
tolic function and thickened pericardium. Although pericardial thick-
ening is not specific, it may be better visualized using TOE.With TTE,
this is better seen either fromparasternal long-axis projections at the
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back of the heart or better from parasternal short-axis projections
with the overall gains right down in order to enhance the echoes
arising from the posterior pericardium. When this is done, then the
pericardial layers may be seen as two bright lines moving in parallel
throughout the cardiac cycle.When this is vizualized, it is very specific
and together with the septal bounce; it will contribute to a positive
diagnosis of pericardial constriction. In addition, the inferior vena
cava is dilated with little respiratory variation indicative of elevated
right atrial pressures.
Mitral inflow velocities may not show respiratory variation in up
to 50% patients with constrictive pericarditis as the filling pressures
may be altered due to marked diuresis, which will tend to reduce
intrathoracic and intracardiac pressures. Therefore, the absence of
respiratory variation ofmitral inflow in patientswith clinical evidence
of significant systemic venous congestion does not exclude the
diagnosis of constrictive pericarditis.72
The respiratory variation of Doppler velocities can also be seen in
other conditions such as chronic obstructive lung disease, right ven-
tricular infarct, sleep apnoea, asthma, and pulmonary embolism due
to increased intrapleural (intrathoracic) pressure drop with inspir-
ation not all transmitted to heart.
Systolic function is preserved in pericardial constriction and this can
also be demonstrated by the highmitral annular systolic velocities, but
also by the high systolic myocardial velocities, strain and strain rate.73
Cardiac catheterization allows simultaneous right ventricular and
LV pressure recordings, demonstrating equalization of pressures at
end-diastole, which gives the typical ‘square root’ or ‘dip and
plateau’ sign (Figure 16). Although not specific to constriction, this
may add to the diagnosis in concert with other clinical and echocar-
diographic findings.
Thickened pericardium byCT can be found in amultitude of situa-
tions, including the early post-operative period, uraemia, rheumatic
heart disease, sarcoidosis, or as a consequence of radiation therapy
(Figure 17). Increased thickness of the pericardium per se does not
constitute proof of constriction.15 About 20% of cases may display
constrictive features without pericardial thickening.72 Also, CT
cannot assess the haemodynamic relevance of a thickened pericar-
dium. Hence the appearance of ‘pericardial thickening’ on CT can
be supportive in cases of suspected constriction, but it does not
prove the condition. Similarly, a normal pericardial thickness
cannot rule out constriction.74 CT imaging can clearly delineate
the presence and the exact extent of pericardial calcification
(Figure 18). In the clinical setting of suspected constriction, pericardial
calcification should be considered a significant finding.20 However,
again, calcificationalonedoesnotallowmaking adiagnosisof ‘pericar-
dial constriction’. CMRcandemonstrate the thickening and, although
less reliably than CT, calcification of the pericardium that are usually
associated with constrictive pericardial disease (Figure 19). Compar-
able with echocardiography, dilated RA, and an elongated RV can be
detected and real-time cine CMR demonstrates ventricular inter-
dependence.41 Pericardial adhesions between the thickened pericar-
dium and the epicardial surface of the myocardium with reduced
mobility of the myocardium may be highlighted by tagged cine
CMR imaging.75,76 CMR findings are used to plan invasive treatment,
such as pericardiectomy, complementing findings on echocardiog-
raphy and/or CT. CMR is frequently used to plan the management
of pericardial masses, in particular surgical interventions. Cardiac
mortality and morbidity at pericardiotomy is mainly caused by the
pre-surgically unrecognized presence ofmyocardial atrophy ormyo-
cardial fibrosis. Using CMR for excluding patients with extensive
Figure 15: Transoesophageal transversal view of pericardial post-operative clots before and after surgical removal.
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myocardial fibrosis and/or atrophy significantly reduces themortality
rate for pericardiotomy.77 Moreover, CMR pericardial LGE and in-
flammatory biomarkers could predict the reversibility of CP after
anti-inflammatory therapy.
Constriction vs. restriction
In most clinical scenarios, the distinction between constriction and
restriction will be guided by the patient’s history. (i.e. of surgery or
infection—tuberculosis). However, in some patients presenting
with elevated filling pressures (diastolic heart failure) and/or pulmon-
ary hypertension the differential diagnosis between pericardial
constriction and restrictive cardiomyopathycanbemorechallenging.
In themajorityof patientswith suspected restrictive cardiomyopathy,
the cause of their pathology is cardiac amyloidosis, which has specific
echocardiographic signs, including reducedcontractility, so that in reality
the differential diagnosis from constrictive pericarditis is rarely an issue.
Other forms of restrictive cardiomyopathies, however, may be more
important for the differential diagnosis with constriction, including
post-radiotherapy, sarcoidosis, haemochromatosis, endomyocardial
fibroelastosis, and primary restrictive cardiomyopathy.
In constrictive pericarditis, the most striking findings are ventricu-
lar septal motion abnormalities, which do not occur in restriction.
Restrictive cardiomyopathy is characterized by the restrictive
Doppler physiology with increased E velocity, decreased A velocity,
E/A ratio greater than 2, and shortened deceleration time of E-wave.
Hepatic vein diastolic flow reversals occur with inspiration instead of
expiration.
Tissue Doppler recording of mitral annulus has become an im-
portantmeans todifferentiatemyocardial restrictive frompericardial
constrictive heart failure. Typically, mitral annular e′ velocity is well
preserved in constriction (often .7 cm/s) (unless mitral annulus
calcification and/or LV dysfunction) but significantly diminished in
restriction. Despite elevated LV filling pressures (restrictive transmi-
tral flow pattern) E/e′ remains low in constrictive pericarditis
(annulus paradoxus). Mitral inflow propagation velocity (PFV) mea-
sured by colour M-mode is also helpful in distinguishing restriction
(PFV ,45 cm/s) from constriction (PFV .45 cm/s). However, it is
more difficult to perform than TDI.73
As shownby Leitman et al.,78 LV rotation and torsionmay bemark-
edly reduced in patients with acute inflammatory pericardial disease.
In these patients, there were also reductions in myocardial longitu-
dinal and circumferential strains. This is probably due to amixed peri-
cardial andmyocardial involvement inmostpatientswith pericarditis.
The marked reduction in LV torsion in patients with perimyocar-
ditis probably reflects reduction in myocardial function predomin-
antly in the subepicardial layer which is composed of the spiral
oblique myocardial fibres which account for the normal counter-
Figure 17: Thickened pericardium—without calcification—in a
non-contrast CT acquisition of a patient with constrictive
pericarditis.
Figure16: Simultaneous right ventricular and left ventricular pressure recordings, demonstrating equalizationof pressures at end-diastole (EDP)
which gives the typical ‘square root’.
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clockwise rotation of the LV apex and clockwise rotation of the
base. In addition, pericardial adhesions may limit the free motion of
the ventricle within the pericardium and thereby reduce LV twist.
The changes in LV torsion in constrictive pericarditis are in prin-
ciple similar to the findings in perimyocarditis, i.e. a marked decrease
in LV torsion, which is mainly due to a reduction in apical rotation.79
Constrictive pericarditis is also associated with reductions in LV lon-
gitudinal, circumferential, and radial strains.80 The reduction in sube-
picardial function in constrictive pericarditis may be attributed to
myocardial atrophy and fibrosis as well as calcium deposition due to
longstanding disease. In myocardial infiltration leading to restrictive
physiology, abnormal LV contraction is usually seen alongside charac-
teristic changes on LGE CMR, with diffuse signal enhancement.78
Effusive-constrictive pericarditis and
transient constrictive pericarditis
Both pericardial effusion and constrictive pericarditis may co-exist in
effusive-constrictive pericarditis. There is a pericardial effusion and
evidence of increased filling pressure with constriction.81,82 Owing
to the decrease in intrapericardial pressure, pericardiocentesis can
solve the constrictive physiology but sometimes constrictive haemo-
dynamics can still persist even after the pericardial effusion is
removed. Pericardiocentesis is the treatment of choice of effusive-
constrictive pericarditis. In patients in whom constriction persists
despite fluid removal, it may be due to reversible inflammation that
may resolve with anti-inflammatory medications, this condition
has been termed transient constrictive pericarditis.83 Gadolinium
Figure 18: Pericardial calcification. In transaxial slices (A and B), the calcified pericardial sections can clearly be seen. Note the impression of the
right ventricle (double arrows in B), indicating the haemodynamic effects of the calcification. (C)An of-axis reconstruction, similar to a ‘short-axis’
view of the heart. Note the infiltration of the myocardium by pericardial calcification (arrow in C). A three-dimensional surface-weighted recon-
struction.
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enhancement of the pericardium has the ability to predict reversibil-
ity of the constrictive physiology.31 If the medical treatment is unsuc-
cessful after a few months of follow-up, a pericardiotomy has to be
planned. In this particular condition, a close follow-up with echo or
CMR to assess the decrease in typical signs and haemodynamics of
constriction is mandatory. The effusion can be followed on anatom-
ical and cine CMR images and inflammatory response tomedications
at the level of the pericardium can be followed using contrast CMR.
Recommendations
Constrictive pericarditis
A. Chronic constrictive pericarditis Class
TTE to confirm clinical diagnosis Recommended
TOE if poor TT quality of imaging (thickness of
pericardium)
Recommended
CT/CMR to confirm clinical diagnosis if
echocardiography inconclusive
Reasonable
CT for planning a pericardiotomy (calcification,
coronary arteries, lung damage, previous
CT surgery, . . .)
Reasonable
CMR for planning pericardiotomy (degree of
myocardial fibrosis and atrophy, lung damage,. . .)
Recommended
TTE for follow-up Recommended
CMR for follow-up Reasonable
B. Effusive-constrictive pericarditis Class
TTE to confirm clinical diagnosis and for follow-up
post-pericardiocentesis
Recommended
CT/CMR to confirm clinical diagnosis if
echocardiography inconclusive
Reasonable
CMR with contrast to evaluate inflammation Reasonable
CMR for follow-up Reasonable
Pericardial tumours, cysts, and diverticula
Most pericardial tumours are secondary lesions due to the local
spread of lung and mediastinal tumours or due to metastatic
lesions from lung and breast cancers, lymphomas, and melanoma.
Primarymalignant tumours are rare, 50% of them aremesothelioma.
Other causes are sarcoma, haemangioma, and teratoma. A pericar-
dial effusion is often associated. The most common cause of
benign tumour of the pericardium is a lipoma. Gossypibomas
(foreign-body granulomas) can also be seen following trauma or
surgery. Although TTE may serve as a screening and follow-up
tool, most neoplasms are best studied with CT or CMR for a
better characterization of the lesion and evaluation of the adjacent
structure of the tumour spread, and to assess the presence of calci-
fication and lymphadenopathy.3 CMR does not provide a histological
diagnosis, but it can provide by its excellent soft tissue differentiation
and large field of view clues for diagnosis and tissue characterization
and can allow delineation, extent, and origin of tumour. Most
tumours will display contrast enhancement and delayed contrast
wash-out.3,84
Cysts are rare, benign, congenital, fluid-filled-loculated-free space
adjacent to cardiac border most of the time at the right costophre-
nic angle. The size may vary from 2 to 28 cm2 and their rupturemay
cause tamponade. In addition to echocardiography, CT and CMR
are techniques of choice to identify the thin walls of these oval,
homogeneous masses. Cysts have a density of 30–40 HU on CT
(Figure 20), showing no enhancement with contrast.85 With CMR,
these structures show intermediate to low-intensity T1-signal
and high T2-weighted signal intensity with no contrast enhance-
ment. Diverticula are out-pouching of the pericardial sac and may
be differentiated from cysts based on the presence of a communi-
cation with the pericardial space and the changes in size related
to the body position.86
Figure 19: Pericardial thickening in constrictive pericarditis
(arrows).
Figure 20: Pericardial cyst in the typical location (right cardio-
phrenic angle) (arrows).
B. Cosyns et al.28
Downloaded from https://academic.oup.com/ehjcimaging/article-abstract/16/1/12/2403250
by UNIV LIEGE FAC PSYCH SCIENCES L'EDUCATION user
on 29 January 2018
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Congenital disease
Congenital absence of the pericardium is very rare, but can also arise
after trauma. It is of a little clinical importance when complete but
may be fatal when it is partial because of a potential herniation of a
part of the heart.Most commonly, partial absence of the pericardium
is left and is usually suspectedwhen theposteriorwallmotion is exag-
gerated or when the right ventricle appears falsely enlarged due to
the left shift. Extreme levorotation and displacement of the apex
may be displaced in the axilla leading to a compressed appearance
of the atria. Interpositionof lung tissue between aorta andpulmonary
artery or between the basis of the heart and the diaphragm is specific
signs. The potential associatedmalformations (such as bicuspid valve,
patent ductus arteriosus, atrial septal defect, and mitral stenosis)
should be explored.
Recommendations
Masses and tumours of the pericardium
TTE to confirm clinical diagnosis Recommended
TOE if poor TT quality of imaging Recommended
CT/CMR to confirm clinical diagnosis and for further
evaluation of the mass and lymphadenopathy
detection
Recommended
Pericardial cysts and diverticula
TTE to confirm clinical diagnosis and follow-up Recommended
Contrast echocardiography to exclude anomalous
systemic vein
Reasonable
CT/CMR to confirm clinical diagnosis Recommended
CT for follow-up Not recommended
Congenital absence of the pericardium
TTE to confirm clinical diagnosis and associated
malformation detection
Recommended




The adipose tissue within the pericardium sac is called ‘epicardial fat’
(frequently, it is incorrectly referred to as ‘pericardial fat’, Figure 21).
An increasing evidence has been accumulated which demonstrates a
relationship between epicardial fat volume and coronary atheroscler-
osis.87 In the past decade, there has been growing interest in the rela-
tionship between epicardial fat and cardiovascular disease. Besides
computed tomography, which does not require the injection of con-
trast agent for this purpose, echocardiography and CMR can also be
used toquantify epicardial adipose tissue.With 2D-echocardiography,
epicardial fat is identifiedas theecho-free spacebetween theepicardial
layers on 2D-images and its thickness is measured on the free wall of
the right ventricle from both parasternal long-axis and short-axis
views at end-diastole. The maximum value at any site is measured,
and the average value is considered. However, computed tomography
provides high-spatial resolution and true volume coverage of the heart
and, therefore, constitutes the most straightforward approach to
quantifying epicardial fat. The extent of epicardial fat and its differenti-
ation from extra-cardiac tissue or myocardial infiltration is usually
straight-forward with CMR. By combining T1-weighted images
withoutandwith fat saturationpreparation, fat canbeconfidently iden-
tified.Especially in suspected infiltrationof theRVfreewallonechocar-
diography, CMR can be a useful second-line investigation.
At the current time, pericardial fat quantification is not included in
recommended algorithms for risk stratification. However, the avail-
able data are intriguing enough to warrant further research.
Conflict of interest: none declared.
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